Clinical Trial: Evaluation of the Safety and Preliminary Efficacy of Neuroinduced Mesenchymal Stem Cells and Exosome Therapy in Patients With Spinocerebellar Palsy

U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT07467733) titled 'Evaluation of the Safety and Preliminary Efficacy of Neuroinduced Mesenchymal Stem Cells and Exosome Therapy in Patients With Spinocerebellar Palsy' on March 09.

Brief Summary: This clinical study aims to evaluate the safety and preliminary therapeutic potential of mesenchymal stem cell-derived therapies in patients diagnosed with spinocerebellar palsy. The investigational treatment includes neuroinduced mesenchymal stem cells and their derived exosomes administered via intravenous and intranasal infusion.

Study Start Date: June 01, 2026

Study Type: INTERVENTIONAL

Condition: Spinocerebellar Ataxia - All Sub-types

Intervention:...